Current problem of chemical gallstone dissolution.
D000818:Animals; D002114:Calcinosis / Q000139:chemically induced; D002635:Chenodeoxycholic Acid / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D002769:Cholelithiasis / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D002784:Cholesterol / Q000097:blood; D003110:Colonic Neoplasms / Q000139:chemically induced; D003362:Cost-Benefit Analysis; D003840:Deoxycholic Acid / Q000031:analogs & derivatives*; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D006801:Humans; D008099:Liver / Q000201:enzymology; D008253:Macaca mulatta; D008297:Male; D000637:Transaminases / Q000097:blood; D014580:Ursodeoxycholic Acid / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use
D003840:Deoxycholic Acid; D002635:Chenodeoxycholic Acid; D014580:Ursodeoxycholic Acid; D002784:Cholesterol; D000637:Transaminases